Slow-release oral morphine as maintenance therapy for opioid dependence

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 6, 2013, Pages

  Ferri, Marica ^a   Minozzi, Silvia ^b   Bo, Alessandra ^a   Amato, Laura ^b  

^a EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

^b DEPARTMENT OF EPIDEMIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHADONE; MORPHINE; PLACEBO; DELAYED RELEASE FORMULATION; NARCOTIC AGENT;

ANXIETY; BECK DEPRESSION INVENTORY; CONSTIPATION; DATA SYNTHESIS; DEPRESSION; DRUG CRAVING; DRUG TOLERABILITY; FATIGUE; HEADACHE; HOUSING; HUMAN; INFLUENZA; INSOMNIA; LEISURE; MAINTENANCE THERAPY; MUSCLE CRAMP; OPIATE ADDICTION; OUTCOME ASSESSMENT; PAIN; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; SLEEP DISORDER; SLOW RELEASE FORMULATION; SOCIAL INTERACTION; STOMACH CRAMP; STOMACH PAIN; SUBSTANCE ABUSE; SYSTEMATIC REVIEW; TOOTH PAIN; VOMITING; DELAYED RELEASE FORMULATION; META ANALYSIS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; DELAYED-ACTION PREPARATIONS; HUMANS; MORPHINE; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84891674624     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD009879.pub2     Document Type: Review

References (35)

1. Clark N, Khoo K, Lintzeris N, Ritter A, Whelan G. A randomised trial of once-daily slow-release oral morphine versus methadone for heroin dependence. Drug and Alcohol Dependence 2002;66 Suppl 1:S33.
2. Eder H, Jagsch R, Kraigher D, Primorac A, Ebner N, Fischer G. Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy. Addiction 2005;100(8):1101-9.
3. Eder H, Kraigher D, Peternel R, Ortner R, Schindler S, Kasper S, et al.Methadone versus slow-relapse morphine maintenance for the treatment of opioid dependence. Drug and Alcohol Dependence 2001;63 Suppl 1:S42.
4. Winklbaur B, Jagsch R, Ebner N, Thau K, Fischer G. Quality of life in patients receiving opioid maintenance therapy. A comparative study of slow-release morphine versus methadone treatment. European Addiction Research 2008;14(2):99-105.
5. Giacomuzzi S, Kemmler G, Ertl M, Riemer Y. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants. Substance Use and Misuse 2006;41(2):223-44.
6. Bond AJ, Reed KDF, Beavan P, Strang J. After the randomised injectable opiate treatment trial: post-trial investigation of slow-release oral morphine as an alternative opiate maintenance medication. Drug and Alcohol Review 2012;31(4):492-8.
7. Madlung-Kratzer E, Spitzer B, Brosch R, Dunkel D, Haring C. A double-blind, randomised, parallel group study to compare the efficacy, safety and tolerability of slow-release oral morphine versus methadone in opioid-dependent in-patients willing to undergo detoxification. Addiction 2009;104(9):1549-57.
8. Mitchell TB, White JM, Somogyi AA, Bochner F. Comparative pharmacodynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence. Drug and Alcohol Dependence 2003;72(1):85-94.
9. Mitchell TB, White JM, Somogyi AA, Bochner F. Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence. Addiction 2004;99(8):940-5.
10. Mitchell TB, White JM, Somogyi AA, Bochner F. Switching between methadone and morphine for maintenance treatment of opioid dependence: impact on pain sensitivity and mood status. American Journal on Addictions 2006;15:311-5.
11. Moldovanyi A, Ladewig D, Affentranger P, Natsch C, Stohler R. Morphine maintenance treatment of opioid-dependent out-patients. European Addiction Research 1996;2:208-12.
12. Fischer G, Presslich O, Diamant K, Schneider C, Pezawas L, Kasper S. Oral morphine-sulfate in the treatment of opiate dependent patients. Alcoholism 1996;32:35-43.
13. Sherman JP. Managing heroin addiction with a long-acting morphine product. The Medical Journal of Australia 1996;165:239.
14. Morphine Slow-release Capsules in Substitution Therapy. Ongoing study October 2006.
15. Amato L, Minozzi S, Davoli M, Vecchi S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database of Systematic Reviews 2011, Issue 10. [DOI: 10.1002/14651858.CD004147]
16. Beer B, Rabl W, Libiseller K, Giacomuzzi S, Riemer Y, Pavlic M. Impact of slow-release oral morphine on drug abusing habits in Austria [Der Einfluss von retardiertem Morphin auf die Drogensituation in Osterreich]. Neuropsychiatrie: Klinik, Diagnostik, Therapie und Rehabilitation: Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater 2010;24(2):108-17. [PUBMED: 20605006]
17. Clark NC, Lintzeris N, Gijsbers A, Whelan G, Dunlop A, Ritter A, et al.LAAM maintenance vs methadone maintenance for heroin dependence. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD002210]
18. Davoli M, Bargagli AM, Perucci CA, Schifano P, Belleudi V, Hickman M, et al.Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction (Abingdon, England) 2007;102:1954-9.
19. European Monitoring Centre for Drugs and Drug Addiction. Annual Report. The State of Drugs Problem in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction, 2011.
20. Faggiano F, Vigna-Taglianti F, Versino E, Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD002208]
21. Ferri M, Bargagli AM, Faggiano F, Belleudi V, Salamina G, Vigna-Taglianti F, et al.Mortality of drug users attending public treatment centres in Italy 1998-2001: a cohort study [Mortalita in una coorte di tossicodipendenti da eroina arruolati presso i Ser.T in Italia, 1998-2001]. Epidemiologia e Prevenzione 2007;31:276-82.
22. Ferri M, Davoli M, Perucci CA. Heroin maintenance for chronic heroin-dependent individuals. Cochrane Database of Systematic Reviews 2011, Issue 12. [DOI: 10.1002/14651858.CD003410]
23. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490.
24. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ. What is 'quality of evidence' and why is it important to clinicians?. BMJ 2008;336:995-8.
25. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al.GRADE guidelines 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2010;64:383-94.
26. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
27. Jegu J, Gallini A, Soler P, Montastruc J L, Lapeyre-Mestre M. Slow-release oral morphine for opioid maintenance treatment: a systematic review. British Journal of Clinical Pharmacology 2011;71(6):832-43.
28. Kastelic A, Dubajic G, Strbad E. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression. Addiction (Abingdon, England) 2008;103:1837-46.
29. Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD002207]
30. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD002209]
31. Schünemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, et al.An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. American Journal of Respiratory and Critical Care Medicine 2006;174:605-14.
32. Soyka M, Kranzler HR, van den Brink W, Krystal J, Moller HJ, Kasper S. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: opioid dependence. The World Journal of Biological Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry 2011;12(3):160-87. [PUBMED: 21486104]
33. United Nations Office on Drugs and Crime. World Drug Report. United Nations Office on Drugs and Crime, No. E.11.XI.10, 2011.
34. van den Brink. Evidence-based pharmacological treatment of substance use disorders and pathological gambling. Current drug abuse reviews 2012;5(1):3-31. [PUBMED: 22126708]
35. World Health Organization. Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. Geneva: World Health Organization, 2009.